HALO logo
halo search icon
ALNEV
Neovacs SA

ALNEV · Neovacs SA

0.61

EUR
-0.0018 (-0.294%)
24/08/2026 12:00:00 AM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

Euro97.35K

PE

0.00

EV/EBITDA

N/A

DIV Yield

0%

Payout Ratio

0%

MQV Rating

5Very Weak

As at 24/08/2026 12:00:00 AM

Price Chart

Description

Neovacs SA is a biotechnology company focused on therapeutic vaccines targeting the treatment of autoimmune diseases. The firm is developing a product portfolio using its Kinoid technology through self-antigens, which cause autoimmune or inflammatory diseases. Its product portfolio includes IFNa kinoid, IL-4/13 kinoid, and IgE kinoid. The company was founded by Daniel Zagury on April 16, 1993 and is headquartered in Paris, France.

  • All-Companies
  • Big Candle
  • HALO All
  • Near 52 Week Low
  • Near Support
  • Volume Spike

Key Fundamentals

EPS 3 yr Growth

-100.00%

EBITDA Margin

NaN%

Operating Cashflow

-€5m

Free Cash Flow Return

-32.20%

ROIC

-31.40%

Interest Coverage

-5.60

Quick Ratio

0.80

Performance

52 weeks range

Low 0.61 - 8099

Trade Value (12mth)

US$9,478.00

1 week

-10.54%

1 month

-17.52%

YTD

-99.3%

1 year

-99.99%

All time high

100000000000000000000.00

Additional Data

Shares Outstanding (Fully Diluted)

37m

HALO Sector

Healthcare

Next Company Report Date

N/A

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

EUR

Short Sell (% of issue)

0.00

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

See beyond the curve.

One solution for research, investing and portfolio management.
Want to learn more?Frequently asked questions.
1
What is the current share price of Neovacs SA (ALNEV:PAR)?
Halo FAQ
The current share price of Neovacs SA (ALNEV:PAR) is EUR€0.61.
2
What is the 52-week high share price for Neovacs SA (ALNEV:PAR)?
Halo FAQ
The 52-week high share price for Neovacs SA (ALNEV:PAR) is EUR€8099.00.
3
What is the 52-week low share price for Neovacs SA (ALNEV:PAR)?
Halo FAQ
The 52-week low share price for Neovacs SA (ALNEV:PAR) is EUR€0.61.
4
What is the dividend yield for Neovacs SA (ALNEV:PAR)?
Halo FAQ
Neovacs SA (ALNEV:PAR) does not pay a dividend.
5
What was Neovacs SA (ALNEV:PAR) last dividend payment?
Halo FAQ
Neovacs SA (ALNEV:PAR) does not pay a dividend.
6
What is the franking level for Neovacs SA (ALNEV:PAR)?
Halo FAQ
Neovacs SA (ALNEV:PAR) has a franking level of 0.00%.
7
In which sector is Neovacs SA (ALNEV:PAR) classified?
Halo FAQ
Neovacs SA (ALNEV:PAR) is classified in the Healthcare.